Price as at:
Fundamentals last refreshed: 13 Nov 2026
Price$1,443.50
Market cap1.3T
P/E46.33
Dividend yield0.47%
52W range$846.81 – $1,458.23
Target price$1,460.30
Overview
Key facts
- Ticker
- LLY
- Exchange
- US
- ISIN
- US5324571083
- Sector
- Healthcare
- Industry
- Drug Manufacturers – General
- Country
- USA
- Currency
- USD
- Price
- $1,443.50
- Previous close
- $1,427.28
- Day change
- +$16.22 (+1.14%)
- Market cap
- 1.3T
- 52W low
- $846.81
- 52W high
- $1,458.23
Price and trend
52W low$846.8152W high$1,458.23
Last price: $1,443.50
- Price
- $1,443.50
- 52W range
- $846.81 – $1,458.23
- 50-day SMA
- $1,230.06
- 200-day SMA
- $1,105.21
- Price vs 50D SMA
- 17.35%
- Price vs 200D SMA
- 30.61%
Valuation
- P/E
- 46.33
- PEG
- 1.33
- EPS
- 30.81
- Dividend yield
- 0.47%
- Beta
- 0.39
Profitability and growth
- Revenue growth
- 38.60%
- Revenue TTM
- 86.5B
- Profit margin
- 31.90%
Analyst view
Last price$1,443.50
+1.16%Distance to target
Analyst target$1,460.30
Comparison uses the last price shown; targets are analyst estimates.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Rating4.3871
strong_buy_count20
buy_count6
hold_count3
sell_count1
strong_sell_count1
- Price
- $1,443.50
- Target price
- $1,460.30
- Target vs last price
- 1.16% from last price
- Rating
- 4.3871
- Analysts
- 31
- strong_buy_count
- 20
- buy_count
- 6
- hold_count
- 3
- sell_count
- 1
- strong_sell_count
- 1
*This content is aimed to provide general information only, and does not take your personal objectives, financial situation or needs into account.
